Speaker 1: Bloomberg Audio Studios, podcasts, radio news, The.
Speaker 2: Stock Movers podcast, your roundup of companies making moves in
Speaker 2: the stock market, harnessing the power of Bloomberg Data.
Speaker 1: Well, let's take a look at some stocks on the
Speaker 1: move today in Europe. I'm Valerie Title with Caroline Hepger,
Speaker 1: when we're joined by Bloomberg's equities reporter Chloe Melay. Chloe.
Speaker 1: Let's start here in the UK with AstraZeneca posting some
Speaker 1: strong earnings.
Speaker 3: Yeah, absolutely good, quite a strong second quarter set of
Speaker 3: results this morning. So we've got better than expected sales
Speaker 3: and rising profit in the second quarter. That's you to
Speaker 3: kind of two main things. So first of all, a
Speaker 3: real focus on cancer medicines, so that's the bet that
Speaker 3: the CEO, Pascal Saria, has made and it's really paying off.
Speaker 3: And then also a really strong focus on the US.
Speaker 3: So you'll remember that very recently AstraZeneca announced a plan
Speaker 3: to invest as much as fifty billion dollars in the
Speaker 3: US by twenty thirty for manufacturing and for recent and development.
Speaker 3: So this focus on the US and this focus on
Speaker 3: oncology is really working well for astra Zeneca. If we
Speaker 3: look at kind of catalysts going forward. A lot actually
Speaker 3: hinges on a potential blockbuster breast cancer drug called Dataway,
Speaker 3: but Ashra said that it was pushing back the results
Speaker 3: of that study on that drug to next year rather
Speaker 3: than this year, so it was supposed to come out
Speaker 3: this year. So investors will be really keeping a close
Speaker 3: eye on this and that will be key for the
Speaker 3: share performance because Ashrazeneka, despite those strong results, has been
Speaker 3: underperforming some of its spears like nevaratists in Switzerland for example,
Speaker 3: So we'll be keeping an eye on that going forward
Speaker 3: as well. Yeah.
Speaker 4: Absolutely, I mean asked a fifty billion dollar manufacturing investment
Speaker 4: in the US is significant. UK lost that on some
Speaker 4: investment too. That was a few months ago, but you
Speaker 4: know that's very significant. Phillips this morning sawing why.
Speaker 3: Yeah, so Phillips said, it's really interesting reversal from Phillips.
Speaker 3: So it actually raised its profitability outlook and there's just
Speaker 3: a couple of months after actually cutting it. So it
Speaker 3: said in it kind of an outlook in May as
Speaker 3: was due to the tariff impact, to the impact of
Speaker 3: the trade war, but then today it said that the
Speaker 3: impact of that trade war was actually not as bad
Speaker 3: as it originally feared. So it raised it again. So
Speaker 3: it's kind of a quick turnaround if you think about
Speaker 3: the fact that it's over the course of just two
Speaker 3: months that it kind of digested that impact and raised
Speaker 3: that outlook again. At the time in May had estimated
Speaker 3: a hit of as much as three hundred million euros.
Speaker 3: Now it sees an impact of just two hundred million,
Speaker 3: so it's quite quite a bit a significant drop there.
Speaker 3: This really provided kind of a relief to the Shes
Speaker 3: They have been struggled. They have been struggling over the
Speaker 3: last year or so. That was due to the trade war,
Speaker 3: which obviously the worries there are lifting a little bit,
Speaker 3: especially with the new trade deal, but then also weakness
Speaker 3: in China and that is still continuing however.
Speaker 1: Yeah so shares a Phillips jumping more than ten percent,
Speaker 1: one of the best performing stocks in Europe this morning,
Speaker 1: very quickly on a Stilantis. A bit of a different
Speaker 1: picture there when it comes to their terraforming.
Speaker 3: Yeah, absolutely so. They are estimating a one point two
Speaker 3: billion euro hit from tariff's in the second half of
Speaker 3: the year. They also lowered the guidance for operating margint
Speaker 3: they see low single digit They had seen mid single
Speaker 3: digit as obviously of the back of the pre release
Speaker 3: that they had last week where they announced that two
Speaker 3: point three billion euro loss and this falsett of earnings
Speaker 3: really did not reassure investors, and we are expecting more
Speaker 3: and more of that tariffon certainty weighing on stillantis and
Speaker 3: on the wider maybe car making sector as well, despite
Speaker 3: that trend deal.
Speaker 2: The Stock Movers podcast from Bloomberg Radio. Check back with
Speaker 2: us throughout the day for the latest roundup of companies
Speaker 2: making news on Wall Street and for the latest market
Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with
Speaker 2: the Bloomberg Business app.